The company changed its name to Urigen Pharmaceuticals Inc. and its ticker to URGP. VLTS reverse-merged with Urigen N.A. Inc. last month (see BioCentury, July 23). Valentis Inc. (VLTS), Burlingame, Calif. Business: Genitourinary, Cardiovascular WIR...

The companies completed their previously announced reverse-merger and will form Urigen Pharmaceuticals Inc. (see BioCentury, Oct. 9, 2006). Valentis' ticker will remain VLTS until its name change is complete. Urigen N.A. Inc. , Burlingame, Calif. Valentis...

Urigen N.A. Inc. , Burlingame, Calif. Business: Genitourinary Resigned: Benson Fong WIR Staff Genitourinary...

Urigen N.A. Inc. , Burlingame, Calif. Business: Genitourinary Hired: Dennis Giesing as director of product development, formerly CEO of CepheidRx LLC WIR Staff...

Urigen N.A. Inc. , Burlingame, Calif. Business: Genitourinary Promoted: Terry Nida to COO from VP of worldwide sales, marketing and corporate development; he replaces Michael Flashner, who departe WIR Staff...